Ocera Therapeutics Inc Share Price

Stocks

02/11/17	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
20/10/17	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
23/08/17	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
01/08/17	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
01/06/17	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
ELI LILLY AND COMPANY	+2.70%	+2.73%	+40.91%	+110.31%	1,060B
JOHNSON & JOHNSON	+1.44%	-2.38%	+36.83%	+63.95%	623B
ABBVIE INC.	+1.75%	+3.73%	+16.55%	+83.05%	480B
MERCK & CO., INC.	+0.60%	-1.73%	+62.98%	+37.46%	352B
ROCHE HOLDING AG	-1.29%	+2.09%	+22.31%	+42.04%	345B
NOVARTIS AG	-0.75%	+0.88%	+11.83%	+35.14%	274B
ASTRAZENECA PLC	-0.76%	-1.50%	-5.35%	+11.42%	249B
AMGEN INC.	+2.60%	-2.00%	+39.77%	+54.44%	223B
GILEAD SCIENCES, INC.	+1.82%	-1.48%	+25.75%	+96.48%	182B
Average	-0.39%	-0.48%	+27.95%	+59.37%	420.89B
Weighted average by Cap.	-0.28%	+0.04%	+31.57%	+70.34%

Employees

Sector